Literature DB >> 15163486

Are influenza surveillance data useful for mapping presentations?

H Uphoff1, I Stalleicken, A Bartelds, B Phiesel, B T Kistemann.   

Abstract

Geographical information system (GIS) based on mappings of influenza data are rare (http://www.b3e.jussieu.fr.80/sentiweb/fr) and influenza data are commonly aggregated for rather large areas (http://www.eiss.org, http://oms2b3e.jussieu.fr/FluNet). The most limiting factors for the use of morbidity-data from practices in GIS-based mappings are differences which are not related to morbidity. These differences may be due to consultation behaviour, interpretation of the case definition, age distribution of patients and other reasons. In order to reduce the impact of these non-morbidity related differences on the interpretation, the data of many practices are usually pooled and consequently rather large areas are presented. Extracting and harmonising the signals for increased morbidity from practices is a presupposition for mapping with a sufficient geographical resolution. The possibility to harmonise by reducing those confounding differences on a practice level is investigated. Different harmonisation methods were applied to data from Germany where acute respiratory infections (ARI) per consultations are registered and from The Netherlands were influenza like illnesses (ILI) per population are registered. The harmonisation of the indices between countries was achieved by scaling them in relation to the level of the index representative for the peak activity during a usual influenza epidemic. The Kriging method is applied as a means of spatial prediction for the influenza data. The preliminary results are discussed with respect to resulting mappings.

Entities:  

Mesh:

Year:  2004        PMID: 15163486     DOI: 10.1016/j.virusres.2004.02.010

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Geodemographics profiling of influenza A and B virus infections in community neighborhoods in Japan.

Authors:  Yoshinari Kimura; Reiko Saito; Yoshiki Tsujimoto; Yasuhiko Ono; Tomoki Nakaya; Yugo Shobugawa; Asami Sasaki; Taeko Oguma; Hiroshi Suzuki
Journal:  BMC Infect Dis       Date:  2011-02-02       Impact factor: 3.090

2.  Validation of a Pediatric Primary Care Network in a US Metropolitan Region as a Community-Based Infectious Disease Surveillance System.

Authors:  Kristen A Feemster; Yimei Li; Robert Grundmeier; A Russell Localio; Joshua P Metlay
Journal:  Interdiscip Perspect Infect Dis       Date:  2011-12-07

3.  Geographical spread of influenza incidence in Spain during the 2009 A(H1N1) pandemic wave and the two succeeding influenza seasons.

Authors:  D Gomez-Barroso; M A Martinez-Beneito; V Flores; R Amorós; C Delgado; P Botella; O Zurriaga; A Larrauri
Journal:  Epidemiol Infect       Date:  2014-01-27       Impact factor: 4.434

4.  Mapping influenza activity in emergency departments in France using Bayesian model-based geostatistics.

Authors:  Juliette Paireau; Camille Pelat; Céline Caserio-Schönemann; Isabelle Pontais; Yann Le Strat; Daniel Lévy-Bruhl; Simon Cauchemez
Journal:  Influenza Other Respir Viruses       Date:  2018-08-21       Impact factor: 4.380

5.  EpiScanGIS: an online geographic surveillance system for meningococcal disease.

Authors:  Markus Reinhardt; Johannes Elias; Jürgen Albert; Matthias Frosch; Dag Harmsen; Ulrich Vogel
Journal:  Int J Health Geogr       Date:  2008-07-01       Impact factor: 3.918

6.  Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe.

Authors:  John Paget; Richard Marquet; Adam Meijer; Koos van der Velden
Journal:  BMC Infect Dis       Date:  2007-11-30       Impact factor: 3.090

Review 7.  [Geographic methods for health monitoring].

Authors:  Daniela Koller; Doris Wohlrab; Georg Sedlmeir; Jobst Augustin
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-09       Impact factor: 1.513

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.